A Tale of Two Pills and a Shot : Emerging Meds for SUD
A Tale of Two Pills and a Shot : Emerging Meds for SUD

The Addiction Files

In this episode we review weekly injectable buprenorphine, and several studies on novel treatments for alcohol use disorders. Will GLP 1's and spironolactone be helpful to reduce drinking days and can naltrexone be used PRN for alcohol use disorder? ...

InformativeHopefulSupportiveEmpoweringEducational

29:42•27 Jun 2023

RSS Feed

About this podcast

The Addiction Files

Darlene Petersen, MD and Paula Cook, MD

Darlene Petersen, MD and Paula Cook, MD are board certified addiction medicine and family medicine physicians providing evidence based education, clinical pearls and resources to physicians, residents and students while striving to destigmatize the treatment of addiction in our medical culture and save lives. Tune in to learn about the latest treatments for all things addiction. Join us as we conduct expert interviews, review clinical pearls and best practices and discuss the latest updates in addiction medicine. No explicit language but this podcast discusses the abuse and treatment of legal and illegal drugs and may not be appropriate for all listeners.

Understanding AddictionDependencyNutritionTreatmentsSobriety Toolkit

Episodes: 102

View Podcast Visit External Site

Do you want to link to this podcast?
Get the buttons here!

New Frontiers in Addiction Treatment: Buprenorphine, GLP-1, and Beyond

Episode Overview

Discussion on Brixati, a new extended-release injectable buprenorphine product with different dosing options
Exploration of GLP-1's potential in reducing alcohol consumption based on rat studies and human trials
Insights into spironolactone's impact on alcohol use disorder and its potential as a treatment
Evaluation of the effectiveness of PRN naltrexone in curbing binge drinking, particularly in specific populations
Hope for more tools in treating addiction and the importance of staying updated with the latest research

“The hosts provide insights into the clinical implications and hope for more tools in treating addiction.”

Imagine having more tools in the fight against addiction. That's exactly what Dr. Darlene Petersen and Dr. Paula Cook explore in this episode of 'The Addiction Files'. They dive into the latest advancements in addiction medicine, focusing on emerging medications that could change the landscape of treatment. Ever heard of Brixati? It's an extended-release injectable buprenorphine product offering weekly and monthly dosing options. The hosts discuss its potential to revolutionize treatment plans for those struggling with opioid use disorder.

But that's not all. The episode also covers intriguing studies on GLP-1 medications and their potential to reduce alcohol consumption. Could these diabetes drugs offer a new way to tackle alcohol use disorder? Drs. Petersen and Cook weigh in with their expert opinions. Additionally, they examine the role of spironolactone in managing alcohol use disorder and the effectiveness of PRN naltrexone for curbing binge drinking.

If you're a medical professional or someone interested in the latest treatment options for addiction, this episode is packed with valuable insights and practical information.

PreviousButalbital and Promethazine Misuse ”Do not fall into the Daily Fiorcet and Phenergan Trap”

NextAccessing the best level of care: How do you know and where do you go?